StockWatch
·
Biotechnology: Pharmaceutical Preparations
ShareholdingJun 3, 2026, 04:31 PM

Cellectis Reports May 31, 2026, Share Capital and Voting Rights

AI Summary

Cellectis S.A. announced its total number of shares in capital and voting rights as of May 31, 2026. The company reported 100,691,658 shares in capital and 106,134,467 total voting rights.

Key Highlights

  • Total number of shares in capital as of May 31, 2026: 100,691,658.
  • Total number of voting rights as of May 31, 2026: 106,134,467.